News
News of a trade secrets leak involving TSMC and an action in Japan against AI startup Perplexity were also among the top ...
American pharmaceutical giant Pfizer and German biotech firm BioNTech will pay Britain’s GSK and Germany’s CureVac US$740 ...
When COVID-19 cases were surging, Dr. David Wohl saw patients “hungry for air” fill UNC hospital wards. What most saved lives ...
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
RNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of ...
In Danes over age 65, the vaccine effectiveness of the JN.1-based mRNA boosters reached 70-85% against COVID-related hospitalization and 76-96% against COVID-associated death. Despite the shift away ...
Infectious disease experts say the mRNA technology used in vaccines is safe, and they credit its development during the first Trump administration with slowing the 2020 coronavirus pandemic.
Messenger RNA vaccines, or mRNA, differ from traditional ones. Instead of growing a virus and weakening it to allow the body to engage its natural defenses, mRNA vaccines use pieces of genetic code to ...
In justifying the government's termination of $500 million in funding for mRNA vaccine projects, Health and Human Services ...
Like Like Love Haha Wow Sad Angry The Department of Health and Human Services (HHS) announced Tuesday it was canceling nearly ...
The decision to cancel almost $500 million dollars in U.S. funding for the development of messenger RNA vaccines is dangerous ...
The Department of Health and Human Services will cancel contracts and pull funding for some vaccines that are being developed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results